tizanidine hydrochloride

Generic: tizanidine hydrochloride

Labeler: cadila pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine hydrochloride
Generic Name tizanidine hydrochloride
Labeler cadila pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 6 mg/1

Manufacturer
Cadila Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 71209-066
Product ID 71209-066_6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210021
Listing Expiration 2026-12-31
Marketing Start 2017-12-29

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71209066
Hyphenated Format 71209-066

Supplemental Identifiers

RxCUI
485484 485485 485486
UPC
0371209064071 0371209065078 0371209066075
UNII
B53E3NMY5C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine hydrochloride (source: ndc)
Generic Name tizanidine hydrochloride (source: ndc)
Application Number ANDA210021 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/1
source: ndc
Packaging
  • 150 CAPSULE in 1 BOTTLE (71209-066-07)
source: ndc

Packages (1)

71209-066-07 150 CAPSULE in 1 BOTTLE (71209-066-07)

Ingredients (1)

tizanidine hydrochloride (6 mg/1)

Linked Drug Pages (1)

Tizanidine hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1", "openfda": {"upc": ["0371209064071", "0371209065078", "0371209066075"], "unii": ["B53E3NMY5C"], "rxcui": ["485484", "485485", "485486"], "spl_set_id": ["f2f4e117-0318-4bbd-aaa7-fab803714f21"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE in 1 BOTTLE (71209-066-07)", "package_ndc": "71209-066-07", "marketing_start_date": "20171229"}], "brand_name": "Tizanidine hydrochloride", "product_id": "71209-066_6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "71209-066", "generic_name": "Tizanidine hydrochloride", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine hydrochloride", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "6 mg/1"}], "application_number": "ANDA210021", "marketing_category": "ANDA", "marketing_start_date": "20171229", "listing_expiration_date": "20261231"}